Hitachi Medical Systems Europe Holding AG
2
Hitachi Medical Systems Europe introduces "LISENDO 880", the new premium 2D/4D Cardiovascular Ultrasound System, featuring HDAnalyticsTM by Hitachi at EuroEcho Imaging 2017
mehr
Storys aus Zug
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
DGAP-News: LION E-Mobility AG: First Details of the LION Smart LIGHT Battery Concept
DGAP-News: LION E-Mobility AG / Key word(s): Research Update/Miscellaneous LION E-Mobility AG: First Details of the LION Smart LIGHT Battery Concept 05.12.2017 / 07:30 The issuer is solely responsible for the content of this announcement. 635613 05.12.2017 ...
mehrDGAP-News: LION E-Mobility AG: Daniel Quinger, President of LION E-Mobility, as speaker at the 3M expert forum 'Fascination eMobility'
DGAP-News: LION E-Mobility AG / Key word(s): Conference/Miscellaneous LION E-Mobility AG: Daniel Quinger, President of LION E-Mobility, as speaker at the 3M expert forum 'Fascination eMobility' 29.11.2017 / 09:00 The issuer is solely responsible for the content of this announcement. 633577 29.11.2017 ...
mehrDGAP-News: LION E-Mobility AG: LION Smart GmbH announces application of another 13 patents
DGAP-News: LION E-Mobility AG / Key word(s): Patent/Research Update LION E-Mobility AG: LION Smart GmbH announces application of another 13 patents 24.11.2017 / 11:02 The issuer is solely responsible for the content of this announcement. 632461 24.11.2017 ...
mehrDGAP-News: LION E-Mobility AG: LION E-Mobility extends successful, strategic investment further
DGAP-News: LION E-Mobility AG / Key word(s): Investment/Alliance LION E-Mobility AG: LION E-Mobility extends successful, strategic investment further 16.11.2017 / 14:18 The issuer is solely responsible for the content of this announcement. 630141 16.11.2017 ...
mehrDGAP-News: LION E-Mobility AG: continues to accelerate its growth with fresh capital from the current capital increase, accompanied by VTC Capital and CM Equity AG
DGAP-News: LION E-Mobility AG / Key word(s): Capital Increase/Corporate Action LION E-Mobility AG: continues to accelerate its growth with fresh capital from the current capital increase, accompanied by VTC Capital and CM Equity AG 29.09.2017 / 13:16 The issuer is solely responsible for the content of this ...
mehr
DGAP-News: LION E-Mobility AG: LION Smart GmbH at the Battery Show North America and at the Automotive Battery Management Systems Conference
DGAP-News: LION E-Mobility AG / Key word(s): Conference/Miscellaneous LION E-Mobility AG: LION Smart GmbH at the Battery Show North America and at the Automotive Battery Management Systems Conference 08.09.2017 / 08:00 The issuer is solely responsible for the content of this announcement. 607807 08.09.2017 ...
mehrEQS-Adhoc: EEII AG publishes half-year results per 06-30-2017
EQS Group-Ad-hoc: EEII AG / Key word(s): Half Year Results EEII AG publishes half-year results per 06-30-2017 06-Sep-2017 / 06:53 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 607095 06-Sep-2017 CET/CEST ...
mehrDGAP-News: LION E-Mobility AG: Half-Year Figures of TUEV SUED and LION Smart GmbH
DGAP-News: LION E-Mobility AG / Key word(s): Half Year Results/Miscellaneous LION E-Mobility AG: Half-Year Figures of TUEV SUED and LION Smart GmbH 31.07.2017 / 20:30 The issuer is solely responsible for the content of this announcement. 597473 31.07.2017 ...
mehrEQS-News: Zug Estates Holding AG: Building permission for university campus legally binding
EQS Group-News: Zug Estates Holding AG / Key word(s): Real Estate Zug Estates Holding AG: Building permission for university campus legally binding 27.07.2017 / 06:55 595827 27.07.2017 ...
mehrDGAP-News: Swiss Merchant Group AG: Equity Participation and Debt Financing of Evan Group Plc
DGAP-News: Swiss Merchant Group AG / Key word(s): Bond/Investment Swiss Merchant Group AG: Equity Participation and Debt Financing of Evan Group Plc 24.07.2017 / 12:22 The issuer is solely responsible for the content of this announcement. 591953 24.07.2017 ...
mehrDGAP-News: LION E-Mobility AG Founds 100% Subsidiary in the U.S.
DGAP-News: LION E-Mobility AG / Key word(s): Expansion/Strategic Company Decision LION E-Mobility AG Founds 100% Subsidiary in the U.S. 18.07.2017 / 08:16 The issuer is solely responsible for the content of this announcement. 593463 18.07.2017 ...
mehr
DGAP-Adhoc: LION E-Mobility AG: LION Smart GmbH signs exclusive supply agreement for its battery management system with Kreisel Electric GmbH
DGAP-Ad-hoc: LION E-Mobility AG / Key word(s): Incoming Orders/Alliance LION E-Mobility AG: LION Smart GmbH signs exclusive supply agreement for its battery management system with Kreisel Electric GmbH 27-Jun-2017 / 15:50 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a ...
mehrShire Pharmaceuticals Group Plc
Shire Announces EMA Validation of Veyvondi[TM] [Von Willebrand Factor (Recombinant)] Marketing Authorization Application for Treatment of Von Willebrand Disease
Zug, Switzerland (ots/PRNewswire) - VEYVONDI is the first and only recombinant von Willebrand factor treatment for adults with von Willebrand disease, the most common inherited bleeding disorder[1],[2],[3] Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare ...
mehrDGAP-News: LION E-Mobility AG: Starts to expand its activities to China, the Worlds' second largest EV Market
DGAP-News: LION E-Mobility AG / Key word(s): Strategic Company Decision/Expansion LION E-Mobility AG: Starts to expand its activities to China, the Worlds' second largest EV Market 14.06.2017 / 18:29 The issuer is solely responsible for the content of this announcement. 583153 14.06.2017 ...
mehrShire Pharmaceuticals Group Plc
Shire to Highlight New Research Into Chronic Hypoparathyroidism at the European Congress of Endocrinology
Zug, Switzerland (ots/PRNewswire) - New clinical and real-life data in chronic hypoparathyroidism, to advance understanding of this rare disease and improve patients' lives Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, announced today new research to be presented on rhPTH(1-84) and on the ...
mehrDGAP-Adhoc: LION E-Mobility AG: LION E-Mobility AG invests in Inboard Technology
DGAP-Ad-hoc: LION E-Mobility AG / Key word(s): Investment/Miscellaneous LION E-Mobility AG: LION E-Mobility AG invests in Inboard Technology 18-May-2017 / 19:21 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ...
mehrShire Pharmaceuticals Group Plc
Shire Granted EU Conditional Marketing Authorisation for Natpar[®] (Parathyroid Hormone) for the Treatment of Patients with Chronic Hypoparathyroidism
Zug, Switzerland (ots/PRNewswire) - Natpar is the first and only licensed recombinant human parathyroid hormone therapy for chronic hypoparathyroidism Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the European Commission (EC) has granted Conditional Marketing Authorisation for Natpar (rhPTH[1-84]), the ...
mehr
Shire Pharmaceuticals Group Plc
Shire Launches #PIPostsThanks Social Campaign to Raise Awareness of Primary Immunodeficiency (PI)
Zug, Switzerland (ots/PRNewswire) - Shire launches campaign to raise global awareness during World PI Week Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, is launching #PIPostsThanks, a social campaign to spotlight the unsung heroes who make a difference in the lives of people living with primary immunodeficiency (PI). PI is a group of nearly ...
mehrShire Pharmaceuticals Group Plc
Shire plc: Data Show A Bleeding Episode Occurs Every Three to 15 Seconds in People Living With Hemophilia Worldwide
Zug, Switzerland (ots/PRNewswire) - On World Hemophilia Day 2017, Shire challenges the community to collectively improve global standards of care for rare bleeding disorders Shire plc (LSE: SHP, NASDAQ: SHPG), a leading biotechnology company focused on serving individuals with rare diseases, joins the global ...
mehrEQS-Adhoc: General meeting of shareholders of Zug Estates Holding AG approves all proposals of the board of directors
EQS Group-Ad-hoc: Zug Estates Holding AG / Key word(s): AGM/EGM General meeting of shareholders of Zug Estates Holding AG approves all proposals of the board of directors 11-Apr-2017 / 17:35 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 564229 11-Apr-2017 CET/CEST ...
mehrDGAP-News: LION E-Mobility AG: ?Seasoned Global Technology (Telecom and Transportation) Executive Joins LION E-Mobility to Drive the Company's International Expansion
DGAP-News: LION E-Mobility AG / Key word(s): Change of Personnel/Strategic Company Decision LION E-Mobility AG: Seasoned Global Technology (Telecom and Transportation) Executive Joins LION E-Mobility to Drive the Company's International Expansion 10.04.2017 / 10:48 The issuer is solely responsible for the ...
mehrShire Pharmaceuticals Group Plc
INTUNIV® (Guanfacine Hydrochloride Prolonged Release), a Non-stimulant for the Treatment of ADHD, Receives Approval in Japan
Zug, Switzerland (ots/PRNewswire) - A New Non-stimulant Clinical Option for Children and Adolescents From 6 to 17 Years old With ADHD Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that its partner in Japan, Shionogi & Co., Ltd, has received the approval of the Japanese Ministry of Health, Labor and Welfare to ...
mehrShire Pharmaceuticals Group Plc
Shire Receives European Approval for Label Extension of CINRYZE®(C1 inhibitor [human]) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE
Zug, Switzerland (ots/PRNewswire) - CINRYZE is now the first and only Hereditary angioedema treatment approved for routine prevention in paediatrics Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the European Commission (EC) has approved a label extension granting three new indications for CINRYZE® (C1 inhibitor ...
mehr
EQS-Adhoc: EEII AG: EEII AG publishes annual results 2016
EQS Group-Ad-hoc: EEII AG / Key word(s): Final Results/AGM/EGM EEII AG: EEII AG publishes annual results 2016 15-March-2017 / 06:47 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 554165 15-March-2017 CET/CEST ...
mehrEQS-Adhoc: Zug Estates heading for further growth
EQS Group-Ad-hoc: Zug Estates Holding AG / Key word(s): Final Results Zug Estates heading for further growth 10-March-2017 / 06:55 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 552719 10-March-2017 CET/CEST ...
mehrDGAP-Adhoc: ?LION E-Mobility AG: Preliminary annual results of LION Smart GmbH
DGAP-Ad-hoc: LION E-Mobility AG / Key word(s): Preliminary Results/Miscellaneous LION E-Mobility AG: Preliminary annual results of LION Smart GmbH 28-Feb-2017 / 18:09 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ...
mehrShire Pharmaceuticals Group Plc
CHMP Recommends EU Conditional Marketing Authorisation for Natpar® (Parathyroid Hormone) for Patients with Chronic Hypoparathyroidism
Zug, Switzerland (ots/PRNewswire) - This Press Release is intended for Global Use If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the management of chronic hypoparathyroidism, the only endocrine-deficiency disorder with no hormone treatment[1] Shire plc (LSE: SHP, ...
mehrShire Pharmaceuticals Group Plc
New Data From Shire Aim To Help Close the Diagnosis and Treatment Gap for People With Hemophilia
Zug, Switzerland (ots/PRNewswire) - Shire presentations at EAHAD 2017 underscore the company's leadership in improving global standards of care Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare diseases, presented its new estimate of the Global Annual Bleed Rate (GABR), an effort to build on current global ...
mehrEQS-Adhoc: Successful first issuance of a CHF 100 million fixed-interest bond by Zug Estates
EQS Group-Ad-hoc: Zug Estates Holding AG / Key word(s): Real Estate/Bond Successful first issuance of a CHF 100 million fixed-interest bond by Zug Estates 24-Jan-2017 / 17:35 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR 538677 24-Jan-2017 CET/CEST ...
mehr
Vorherige123456789Nächste